Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianmin Luo

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Research|January 15, 2020
Therapy-Induced Senescence Drives Bone LossZhangting Yao, Bhavna Murali, Qihao Ren, et al.
Nature Communications|June 9, 2016
Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesisMegan K Ruhland, Andrew J Loza, Aude-Helene Capietto, et al.
Cell Reports|January 4, 2016
Stromal-Initiated Changes in the Bone Promote Metastatic Niche DevelopmentXianmin Luo, Yujie Fu, Andrew J Loza, et al.
Cancer Research|August 11, 2018
Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone LossBhavna Murali, Qihao Ren, Xianmin Luo, et al.
Cancer Discovery|April 29, 2024
Senescent CAFs Mediate Immunosuppression and Drive Breast Cancer ProgressionJiayu Ye, John M Baer, Douglas V Faget, et al.
Cancer Discovery|March 8, 2023
p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to ImmunotherapyDouglas V Faget, Xianmin Luo, Matthew J Inkman, et al.
Signal Transduction and Targeted Therapy|December 23, 2024
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trialJia Zhong, Kailun Fei, Lin Wu, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Research|January 15, 2020
Therapy-Induced Senescence Drives Bone LossZhangting Yao, Bhavna Murali, Qihao Ren, et al.
Nature Communications|June 9, 2016
Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesisMegan K Ruhland, Andrew J Loza, Aude-Helene Capietto, et al.
Cell Reports|January 4, 2016
Stromal-Initiated Changes in the Bone Promote Metastatic Niche DevelopmentXianmin Luo, Yujie Fu, Andrew J Loza, et al.
Cancer Research|August 11, 2018
Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone LossBhavna Murali, Qihao Ren, Xianmin Luo, et al.
Cancer Discovery|April 29, 2024
Senescent CAFs Mediate Immunosuppression and Drive Breast Cancer ProgressionJiayu Ye, John M Baer, Douglas V Faget, et al.
Cancer Discovery|March 8, 2023
p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to ImmunotherapyDouglas V Faget, Xianmin Luo, Matthew J Inkman, et al.
Signal Transduction and Targeted Therapy|December 23, 2024
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trialJia Zhong, Kailun Fei, Lin Wu, et al.
Pageof 2